ITUS Corporation

(ITUS)

By |

Profile

ITUS Corp funds, develops, acquires & licenses emerging technologies in biotechnology. Its subsidiary Anixa Diagnostics Corp is developing a platform called Cchek, a series of non-invasive blood tests for the early detection of solid tumor based cancers.

Contact Information

Website: www.ituscorp.com
Main Phone: +1 310 484-5200
Address: 12100 Wilshire Boulevard
Address 2: Suite 1275
State: CA
City / Town: Los Angeles
Country: USA
Postal Code: 90025

Issuer Information

Exchange: NSC
Employees: 6
NAICS: All Other Busine
$ 5.40 $ 0.00 (0.00%)
Last Price 5.40 Change $ 0.00 Change % 0.00 Tick N/A
Bid 0.00 Bid Size 0.00 Ask 0.00 Ask Size 0.00
Open 5.25 High 6.25 Low 5.25 Prev Close 5.40
Last Trade Volume 79,119 52 Wk Hi 6.82 52 Wk Low 1.88
Market Cap 47.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 8,747,753.00 EPS (TTM) -0.61 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 14 50
Number of Buys 11 43
Number of Sells 3 7
Net Activity 11304 34921
Last 10 Buys Shares
Bruce F. Johnson 1,000
Bruce F. Johnson 1,000
Bruce F. Johnson 1,000
Bruce F. Johnson 1,000
Bruce F. Johnson 1,000
Bruce F. Johnson 1,000
Bruce F. Johnson 1,000
Bruce F. Johnson 1,000
Bruce F. Johnson 1,000
Bruce F. Johnson 1,000
Last 10 Sell Shares
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
Henry P. Herms 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.12 1.12 1.12 1.12
Low Target Price Estimate 1.12 1.12 1.12 1.12
Mean Target Price Estimate 1.12 1.12 1.12 1.12
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/14/14 04/14/14 04/14/14 04/14/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago